https://www.itmp.fraunhofer.de/en/institute/DrugDiscovery.html The first two to do this were Head of Drug Development, Aimo Kannt from Fraunhofer Institute for Molecular Biology and Applied Ecology, and Assistant Professor Janice Hwang from Yale School of Medicine. Aimo Kannt. After a short coffee break, Dr. Sheraz Gul, head of innovation area Drug Screening & Substance Repurposing at Fraunhofer ITMP, presented … Total downloads of all papers by Aimo Kannt. Aimo Kannt. Inventors: Aimo KANNT, Maximilian BIELOHUBY, Ralf ELVERT, Michael WAGNER, Martin BOSSART, Torsten HAACK, Stephanie KEIL, Werner SEIZ A NOVEL SOLUBLE BIOMARKER FOR INSULIN RESISTANCE. AIOLOS, a Franco-German consortium, launches development of a … Auditorium 2: Technologie-Trends. Search for more papers by this author. View ePoster. Aimo Kannt 1 ,2 3 *and Ivan ikic 4 5 6 1 Fraunhofer Institute of Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany 2 Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany PD Dr. Frank Behrens. Michael Baßler Liquid Biopsy: Automatisierung für zukunftsweisende Krebsforschung. Fraunhofer-Institut Ombudsperson Stellvertretung Die AIMO™ Gesundheitsprüfung. Dr. Ronald Rösch Prof. Ralf Korn Fraunhofer-Institut für Verkehrs-und Infrastruktursysteme . Am Donnerstag, 29. Importantly, respiratory pathogens do not stop at national borders, which is why partners from France and Germany join forces and combine their skills and capabilities to be better prepared for upcoming outbreaks”, says Dr Aimo Kannt, from the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP. PD Dr. Aimo Kannt, Forschungsbereichsleiter Drug Discovery am Fraunhofer ITMP, stellte Forschungsarbeiten zur neuen Arzneimittelklasse »ProxiDrugs« vor. Aimo Kannt – Deutschland | Berufsprofil | LinkedIn Dr. Aimo Kannt, Sanofi-Aventis Deutschland GmbH, Industriepark Höchst G 838, Frankfurt am Main DFG - GEPRIS - Dr. Aimo Kannt Direkt zum Inhalt springen Direkt zu Textvergrößerung und Kontrast springen . Aimo Kannt. Fraunhofer … Andrea Zaliani. Incretin combination therapy for the treatment Comments. 10.00 Begrüßung durch Moderatorin Christiane Stein. Authors. CGM beteiligt sich an AIOLOS-Projekt - cgm.com Aimo Kannt, Sanofi Research and Development, D-65926 Frankfurt, Germany. Auditorium 2: Technologie-Trends . Fraunhofer Institute for Molecular Biology and Applied Ecology, Fraunhofer Society (FHG) Aachen, Germany.